“canadians are asking for more breast cancer data, and there is a clear need to address the lack of information available. through a patient-centered approach, progress tracker will guide the development of new interventions that will directly impact breast cancer care, whether it is starting routine mammograms at an earlier age or potentially shortening the number of radiation treatments in one’s journey,” said kimberly carson, breast cancer canada ceo. “through our mission to know more, breast cancer canada is proud to introduce canada’s largest cancer pros research initiative, and we are excited to have canadians participate from any postal code.”
progress tracker aims to uncover the breast cancer experience directly from the best source – the patient. nationally and locally, progress tracker can alert researchers and cancer programs to lived-experienced insights in an accessible way. groups such as researchers, oncologists, cancer programs and corporations will be able to request anonymous data from the registry for analysis of clinical symptoms and side effects over time. this registry will be active for 20 years and data will live in perpetuity with real-time analysis and updates to advance timely research and care.
dr. omar khan, a medical oncologist specializing in breast cancer at the tom baker cancer centre in calgary, alberta, is one of the principal investigators of progress tracker. his research focuses on using artificial intelligence (ai) to improve outcomes for patients with cancer, and he has helped develop the progress tracker registry to help elevate the patient voice.
“to truly understand how to drive change in health systems to improve the lives of patients, we must also listen to their voices,” stated dr. khan. “having a robust data registry allowing us to follow the lived experiences of patients throughout all aspects of their breast cancer journey, and combining this with evolving technologies and ai is key to unlocking the full potential of precision medicine. thanks to breast cancer canada’s leadership, we will be able to better put our patients first when exploring new ways of collecting and analyzing data.”